NCT06153576
- Conditions
- Bone Metastases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- CHU NICE Nice, Alpes Maritimes, France
Clinical trial condition
Myeloma
Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.
114 public trials
22 recruiting studies
Myeloma trial results
NCT04703985
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- CH de la Côte Basque Bayonne, France
- CHU Bordeaux Bordeaux, France
Completed
Pedometer Activity Monitoring After ASCT
NCT03238599
- Conditions
- Autologous Stem Cell Transplantation, Hemic and Lymphatic Diseases, High-dose Chemotherapy, +9 more
- Locations
-
- Departement of Medical Oncology, University Hospital Berne Bern, Switzerland
NCT00001582
- Conditions
- ATL, Autoimmune Diseases, B-cell Lymphoma, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT02593123
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +45 more
- Locations
-
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
NCT02403102
- Conditions
- Cancer, Myeloma, Neoplasms, +2 more
- Locations
-
- The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
NCT01793051
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00907452
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- CH ALBI Albi, France
- CHRU Angers Angers, France
- CH Côte basque Bayonne, France
- CH Blois Blois, France
NCT00469209
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT01885897
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
- Washington University St Louis, Missouri, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States